Behavioral Healthcare - New ABILIFY formulation
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd., have launched ABILIFY[R] DISCMELT[TM] (aripiprazole) Orally Disintegrating Tablets, an oral form of the antipsychotic medication aripiprazole that disintegrates rapidly in the mouth. The FDA approved ABILIFY DISCMELT on June 7. For full prescribing information, including boxed warning, visit www.abilify.com.
Related Results
Abilify approvalAbilify approvalNew AbilifyAbilify available as oral solutionAbilify wins clearance
[ILLUSTRATION OMITTED]
COPYRIGHT 2006 Vendome Group LLC
COPYRIGHT 2008 Gale, Cengage Learning
